Status:
RECRUITING
The COherence of Scatter Identification and Exclusion Algorithm Study
Lead Sponsor:
Institute of Cancer Research, United Kingdom
Collaborating Sponsors:
Imperial College London
Royal Marsden NHS Foundation Trust
Conditions:
Steatohepatitis, Nonalcoholic
Eligibility:
All Genders
18+ years
Brief Summary
Non-alcoholic fatty liver disease (NAFLD) is currently the most common liver condition worldwide; approximately 55% of the world population will have NAFLD by 2040. NAFLD is an unwanted side effect of...
Eligibility Criteria
Inclusion
- Healthy Volunteers:
- Healthy male or female adults (18 or above).
- Volunteers must consider themselves fit and healthy.
- RMH and/or ICR employees.
- Patients:
- Patients undergoing liver MRI as part of clinical standard of care with evidence of steatosis on preceding MRI.
- Aged 18 and above.
Exclusion
- Healthy Volunteers:
- Volunteers that are under investigation or planning to consult their GP to seek investigation for an undiagnosed condition, particularly regarding pelvic or abdominal disease or injury.
- Healthy volunteers who do not have an NHS number or who are not registered with a GP will be excluded.
- Patients:
- • Severe liver fibrosis (fibrosis stage F4) or severe cirrhosis.
Key Trial Info
Start Date :
August 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06975579
Start Date
August 27 2024
End Date
June 30 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Marsden Hospital
London, Greater London, United Kingdom, SM2 5NG